Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 31.71
-0.01 (-0.03%)
At close: Jul 27, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 13.94 billion as of July 28, 2026. Its market cap has increased by 63.09% in one year.
Market Cap
13.94B
Enterprise Value
13.93B
Revenue
567.27M
Ranking
n/a
PE Ratio
63.42
Stock Price
31.71
ChartMarket Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 13.94B, an increase of 30,098.91%. That is a compound annual growth rate of 48.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 13.94B | -46.27% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 20.98B |
| TTK Healthcare | 15.30B |
| Amrutanjan Health Care | 14.85B |
| Fredun Pharmaceuticals | 14.80B |
| Fermenta Biotech | 12.73B |
| Syncom Formulations (India) | 12.40B |
| Lincoln Pharmaceuticals | 11.63B |
| Wanbury | 11.56B |